Search Results

There are 62185 results for: content related to: Remission induction in acute myeloid leukemia

  1. You have free access to this content
    Studies on the domain structure of the Salmonella/typhimurium AraC protein

    European Journal of Biochemistry

    Volume 185, Issue 2, November 1989, Pages: 319–325, Hanspeter LAUBLE, Yannis GEORGALIS and Udo HEINEMANN

    Version of Record online : 3 MAR 2005, DOI: 10.1111/j.1432-1033.1989.tb15118.x

  2. A new and unexpected domain–domain interaction in the AraC protein

    Proteins: Structure, Function, and Bioinformatics

    Volume 80, Issue 5, May 2012, Pages: 1465–1475, Stephanie Dirla Cole and Robert Schleif

    Version of Record online : 1 MAR 2012, DOI: 10.1002/prot.24044

  3. You have free access to this content
    Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine

    British Journal of Haematology

    Volume 109, Issue 2, May 2000, Pages: 388–395, Jan Braess, Christine Wegendt, Gerlinde Jahns-Streubel, Wolfgang Kern, Susan Keye, Michael Unterhalt, Eberhardt Schleyer and Wolfgang Hiddemann

    Version of Record online : 3 OCT 2008, DOI: 10.1046/j.1365-2141.2000.02056.x

  4. CYTOSINE ARABINOSIDE IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    Australian and New Zealand Journal of Medicine

    Volume 17, Issue 4, August 1987, Pages: 379–386, J. S. WILEY, R. K. WOODRUFF, G. P. JAMIESON, F. C. FIRKIN and W. H. SAWYER

    Version of Record online : 25 MAR 2008, DOI: 10.1111/j.1445-5994.1987.tb00069.x

  5. AraC protein: A love–hate relationship

    BioEssays

    Volume 25, Issue 3, March 2003, Pages: 274–282, Robert Schleif

    Version of Record online : 20 FEB 2003, DOI: 10.1002/bies.10237

  6. Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates

    International Journal of Cancer

    Volume 47, Issue 2, 21 January 1991, Pages: 281–284, Ladislav Novotný, Eliška Balážová, Jozef šandula, Viliam Ujházy and Vladimír Kéry

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910470218

  7. You have free access to this content
    Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type

    Cancer

    Volume 71, Issue 1, 1 January 1993, Pages: 117–123, Linda M. S. Resar, Peter C. Phillips, Michael B. Kastan, Brigid G. Leventhal, Paul W. Bowman and Curt I. Civin

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19930101)71:1<117::AID-CNCR2820710119>3.0.CO;2-K

  8. You have free access to this content
    Elucidating residue roles in engineered variants of AraC regulatory protein

    Protein Science

    Volume 19, Issue 2, February 2010, Pages: 291–298, Shuang-Yan Tang and Patrick C. Cirino

    Version of Record online : 15 DEC 2009, DOI: 10.1002/pro.310

  9. Cytosine Arabinoside Induces Apoptosis in Cerebellar Neurons in Culture

    Journal of Neurochemistry

    Volume 64, Issue 5, May 1995, Pages: 1980–1987, Frédéric Dessi, Hélène Pollard, Joelle Moreau, Yezekiel Ben-Ari and Christiane Charriaut-Marlangue

    Version of Record online : 23 NOV 2002, DOI: 10.1046/j.1471-4159.1995.64051980.x

  10. You have free access to this content
    Variation of half-site organization and DNA looping by AraC protein.

    The EMBO Journal

    Volume 12, Issue 1, January 1993, Pages: 35–44, J.H. Carra and R.F. Schleif

    Version of Record online : 1 JAN 1993, DOI: 10.1002/j.1460-2075.1993.tb05629.x

  11. Computational and experimental investigation of constitutive behavior in AraC

    Proteins: Structure, Function, and Bioinformatics

    Volume 82, Issue 12, December 2014, Pages: 3385–3396, Mary Lowe, David Gullotti, Ana Damjanovic, Ann Cheng, Stephanie Dirla and Robert Schleif

    Version of Record online : 21 OCT 2014, DOI: 10.1002/prot.24693

  12. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin

    Medical and Pediatric Oncology

    Volume 14, Issue 2, 1986, Pages: 73–77, Eiichi Ishii, Toshiro Hara, Kenshi Ohkubo, Akinobu Matsuzaki, Takami Takeuchi and Kohji Veda

    Version of Record online : 20 JUL 2006, DOI: 10.1002/mpo.2950140203

  13. You have free access to this content
    The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity

    British Journal of Haematology

    Volume 110, Issue 1, July 2000, Pages: 170–179, J. Braess, S. Voß, G. Jahns-Streubel, C. Schoch, T. Haferlach, W. Kern, S. Keye, E. Schleyer and W. Hiddemann

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2141.2000.02151.x

  14. You have free access to this content
    Tuesday, 7 July 1998

    British Journal of Haematology

    Volume 102, Issue 1, July 1998, Pages: 140–269,

    Version of Record online : 22 MAR 2012, DOI: 10.1111/j.1365-2141.1998.tb08996.x

  15. Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma

    Scandinavian Journal of Haematology

    Volume 34, Issue 1, January 1985, Pages: 83–87, Dr. R. Willemze, W. G. Peters, M. B. van Hennik, W. E. Fibbe, A. M. M. Kootte, M. van Berkel, R. Lie, C. J. Rodenburg and J. J. Veltkamp

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1985.tb00748.x

  16. Conformational perturbation of the anticancer nucleoside arabinosylcytosine on Z-DNA: Molecular structure of (araC-dG)3 at 1.3 Å resolution

    Biopolymers

    Volume 32, Issue 11, November 1992, Pages: 1559–1569, Hong Zhang, Gijs A. Van Der Marel, Jacques H. Van Boom and Andrew H.-J. Wang

    Version of Record online : 1 FEB 2004, DOI: 10.1002/bip.360321113

  17. You have free access to this content
    Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a ‘pre-induction’ course for rapid tumour reduction: preliminary results on 66 patients

    British Journal of Haematology

    Volume 100, Issue 2, February 1998, Pages: 273–282, Daenen, van Imhoff, van den Berg, de Kam, Haaxma-Reiche, Vellenga, Smit and Halie

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1998.00559.x

  18. Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay

    British Journal of Haematology

    Volume 58, Issue 4, December 1984, Pages: 633–640, H. D. Preisler and N. Azarnia

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1984.tb06110.x

  19. Haemopoietic growth factors I

    British Journal of Haematology

    Volume 81, Issue s1, August 1992, Pages: 1–429,

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1992.tb08268.x

  20. You have free access to this content
    The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons

    Journal of Neurochemistry

    Volume 96, Issue 5, March 2006, Pages: 1213–1226, Andreas Wyttenbach and Aviva M. Tolkovsky

    Version of Record online : 30 JAN 2006, DOI: 10.1111/j.1471-4159.2005.03676.x